Courtney V. Fletcher, PharmD, reviews data on common drug-drug interactions affecting FDA-approved antiretroviral agents as well as those in expanded access programs and provides recommendations on some of the more difficult interactions that physicians face in clinical practice.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the most common mechanisms underlying drug-drug interactions between antiretroviral agents and other medications commonly used by HIV-infected patients
- Describe common drug-drug interactions affecting US Food and Drug Administration–approved antiretroviral agents and detail dose adjustments where appropriate
- List combinations of antiretroviral agents and other medications that are contraindicated
- Summarize common drug-drug interactions affecting investigational antiretrovirals currently available through expanded access programs